Health In Tech, Inc. Class A Common Stock (HIT)vsSAP SE ADR (SAP)
HIT
Health In Tech, Inc. Class A Common Stock
$1.81
-0.55%
TECHNOLOGY · Cap: $102.44M
SAP
SAP SE ADR
$168.95
-1.20%
TECHNOLOGY · Cap: $217.55B
Smart Verdict
WallStSmart Research — data-driven comparison
SAP SE ADR generates 119678% more annual revenue ($36.80B vs $30.72M). SAP leads profitability with a 19.5% profit margin vs 4.7%. SAP trades at a lower P/E of 26.3x. SAP earns a higher WallStSmart Score of 58/100 (C).
HIT
Hold39
out of 100
Grade: F
SAP
Buy58
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-129.8%
Fair Value
$0.47
Current Price
$1.81
$1.34 premium
Margin of Safety
-88.8%
Fair Value
$104.04
Current Price
$168.95
$64.91 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 90.4% year-over-year
Mega-cap, among the largest globally
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Growing faster than its price suggests
Strong operational efficiency at 29.2%
Generating 1.1B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
4.7% margin — thin
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Moderate valuation
3.3% revenue growth
Comparative Analysis Report
WallStSmart ResearchBull Case : HIT
The strongest argument for HIT centers on Revenue Growth. Revenue growth of 90.4% demonstrates continued momentum.
Bull Case : SAP
The strongest argument for SAP centers on Market Cap, Altman Z-Score, Debt/Equity. Profitability is solid with margins at 19.5% and operating margin at 29.2%. PEG of 0.79 suggests the stock is reasonably priced for its growth.
Bear Case : HIT
The primary concerns for HIT are Market Cap, Profit Margin, P/E Ratio. A P/E of 90.0x leaves little room for execution misses. Thin 4.7% margins leave little buffer for downturns.
Bear Case : SAP
The primary concerns for SAP are P/E Ratio, Revenue Growth.
Key Dynamics to Monitor
HIT profiles as a hypergrowth stock while SAP is a value play — different risk/reward profiles.
HIT is growing revenue faster at 90.4% — sustainability is the question.
SAP generates stronger free cash flow (1.1B), providing more financial flexibility.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SAP scores higher overall (58/100 vs 39/100), backed by strong 19.5% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Health In Tech, Inc. Class A Common Stock
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Health In Tech, Inc. (HIT) is a pioneering force in the convergence of healthcare and technology, committed to revolutionizing care delivery through cutting-edge digital solutions. Leveraging advanced data analytics and proprietary software, HIT enhances decision-making capabilities for healthcare providers and patients alike, thereby elevating patient outcomes and operational efficiencies. With a strong emphasis on compliance and cybersecurity, the company is strategically positioned to capitalize on the burgeoning growth of the digital health market. As the demand for innovative, technology-driven healthcare solutions accelerates, HIT is well-equipped to emerge as a leading player in this transformative landscape.
SAP SE ADR
TECHNOLOGY · SOFTWARE - APPLICATION · USA
SAP SE is a global enterprise application software company. The company is headquartered in Walldorf, Germany.
Visit Website →Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?